Similar articles for PMID: 27170400

Year	Number of Results
1995	2
2001	1
2002	2
2003	1
2004	1
2005	1
2007	3
2008	2
2009	6
2010	2
2011	1
2012	5
2013	7
2014	10
2015	13
2016	10
2017	11
2018	8
2019	6
2020	8
2021	13
2022	18
2023	6
2024	0

1

Molecular Pathogenesis and Current Therapy in Intrahepatic Cholangiocarcinoma.

Høgdall D, O'Rourke CJ, Taranta A, Oliveira DV, Andersen JB. Høgdall D, et al. Dig Dis. 2016;34(4):440-51. doi: 10.1159/000444562. Epub 2016 May 11. Dig Dis. 2016. PMID: 27170400 Review.

2

Molecular pathogenesis of intrahepatic cholangiocarcinoma.

Andersen JB. Andersen JB. J Hepatobiliary Pancreat Sci. 2015 Feb;22(2):101-13. doi: 10.1002/jhbp.155. Epub 2014 Sep 1. J Hepatobiliary Pancreat Sci. 2015. PMID: 25174625 Review.

3

Intrahepatic cholangiocarcinoma: current management and emerging therapies.

Rahnemai-Azar AA, Weisbrod AB, Dillhoff M, Schmidt C, Pawlik TM. Rahnemai-Azar AA, et al. Expert Rev Gastroenterol Hepatol. 2017 May;11(5):439-449. doi: 10.1080/17474124.2017.1309290. Epub 2017 Mar 29. Expert Rev Gastroenterol Hepatol. 2017. PMID: 28317403 Review.

4

Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances.

Sirica AE, Gores GJ, Groopman JD, Selaru FM, Strazzabosco M, Wei Wang X, Zhu AX. Sirica AE, et al. Hepatology. 2019 Apr;69(4):1803-1815. doi: 10.1002/hep.30289. Epub 2019 Mar 25. Hepatology. 2019. PMID: 30251463 Free PMC article. Review.

5

Cholangiocarcinoma.

Krasinskas AM. Krasinskas AM. Surg Pathol Clin. 2018 Jun;11(2):403-429. doi: 10.1016/j.path.2018.02.005. Surg Pathol Clin. 2018. PMID: 29751883 Review.

6

Targeting cholangiocarcinoma.

Mertens JC, Rizvi S, Gores GJ. Mertens JC, et al. Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1454-1460. doi: 10.1016/j.bbadis.2017.08.027. Epub 2017 Aug 24. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 28844952 Free PMC article. Review.

7

Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts.

Raggi C, Invernizzi P, Andersen JB. Raggi C, et al. J Hepatol. 2015 Jan;62(1):198-207. doi: 10.1016/j.jhep.2014.09.007. Epub 2014 Sep 16. J Hepatol. 2015. PMID: 25220250 Free article. Review.

8

YAP1 activation and Hippo pathway signaling in the pathogenesis and treatment of intrahepatic cholangiocarcinoma.

Ko S, Kim M, Molina L, Sirica AE, Monga SP. Ko S, et al. Adv Cancer Res. 2022;156:283-317. doi: 10.1016/bs.acr.2022.02.003. Epub 2022 Mar 9. Adv Cancer Res. 2022. PMID: 35961703 Free PMC article. Review.

9

Molecular perturbations in cholangiocarcinoma: Is it time for precision medicine?

Braconi C, Roessler S, Kruk B, Lammert F, Krawczyk M, Andersen JB. Braconi C, et al. Liver Int. 2019 May;39 Suppl 1:32-42. doi: 10.1111/liv.14085. Epub 2019 Mar 24. Liver Int. 2019. PMID: 30829432 Review.

10

Intrahepatic cholangiocarcinoma arising in multiple bile duct hamartomas: report of two cases and review of the literature.

Xu AM, Xian ZH, Zhang SH, Chen XF. Xu AM, et al. Eur J Gastroenterol Hepatol. 2009 May;21(5):580-4. doi: 10.1097/MEG.0b013e3282fc73b1. Eur J Gastroenterol Hepatol. 2009. PMID: 19282767 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

118 results

Results by year